STRATEC CONSUMABLES GMBH -  

Ranking results:

Past rankings:

2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 2.512.169 255.934 1
2016 0 3.734.781 304.098 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
STIFTELSEN SINTEF2
ACADEMISCH ZIEKENHUIS LEIDEN1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
BIOTRONICS 3D LIMITED1
CELLULAR THERAPEUTICS LIMITED1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
DAS PHOTONICS SL1
DR FOOKEACHTERRATH LABORATORIEN1
EUREXPLOIT1
FUNDACION HOSPITAL LA FE1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
KLINIKUM DER UNIVERSITAET REGENSBURG1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LUMENSIA SENSORS SL1
MEDIZINISCHE UNIVERSITAET WIEN1
OPTOELECTRONICA 20011
SCIENSEED SL1
SONY DADC AUSTRIA1
TECHNISCHE UNIVERSITAET WIEN1
UNIVERSIDAD POLITECNICA DE VALENCIA1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITY OF BRISTOL1

Constancy:

Total number of partners: 24
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 24
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2017-01-01European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry EN_ACTI2NGparticipant2.512.16913
2016-01-01COMPACT BIOPHOTONIC PLATFORM FOR DRUG ALLERGY DIAGNOSIS COBIOPHADparticipant3.734.78113